ARVN
Price
$7.69
Change
-$0.31 (-3.88%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
553.59M
57 days until earnings call
Intraday BUY SELL Signals
CING
Price
$4.91
Change
+$0.88 (+21.84%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
65.59M
Intraday BUY SELL Signals
Interact to see
Advertisement

ARVN vs CING

Header iconARVN vs CING Comparison
Open Charts ARVN vs CINGBanner chart's image
ARVN vs CING Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARVN vs. CING commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CING is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (ARVN: $7.99 vs. CING: $4.03)
Brand notoriety: ARVN and CING are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 95% vs. CING: 727%
Market capitalization -- ARVN: $553.59M vs. CING: $65.59M
ARVN [@Biotechnology] is valued at $553.59M. CING’s [@Biotechnology] market capitalization is $65.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCING’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • CING’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARVN and CING are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while CING’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 5 bearish.
  • CING’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CING is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а -10.43% price change this week, while CING (@Biotechnology) price change was -15.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

ARVN is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($554M) has a higher market cap than CING($65.6M). CING YTD gains are higher at: -7.258 vs. ARVN (-32.631). CING has higher annual earnings (EBITDA): -23.66M vs. ARVN (-248.7M). ARVN has more cash in the bank: 615M vs. CING (25.9M). CING has less debt than ARVN: CING (7.43M) vs ARVN (8.4M). ARVN has higher revenues than CING: ARVN (89.4M) vs CING (0).
ARVNCINGARVN / CING
Capitalization554M65.6M845%
EBITDA-248.7M-23.66M1,051%
Gain YTD-32.631-7.258450%
P/E RatioN/A0.02-
Revenue89.4M0-
Total Cash615M25.9M2,375%
Total Debt8.4M7.43M113%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCING
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signal:
Gain/Loss:
CING
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCSIX42.60N/A
N/A
Sterling Capital SmCp Val R6
IUAEX32.94N/A
N/A
JPMorgan International Focus A
GLVIX94.85N/A
N/A
Invesco Global Focus R6
FLIAX11.04N/A
N/A
First Sentier American Listed Infras I
OAYBX39.09-0.27
-0.69%
Oakmark Equity and Income Advisor

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-6.88%
AXON - ARVN
46%
Loosely correlated
+2.78%
VCYT - ARVN
46%
Loosely correlated
-0.79%
XNCR - ARVN
43%
Loosely correlated
-5.00%
BCYC - ARVN
43%
Loosely correlated
-5.08%
MGX - ARVN
43%
Loosely correlated
+1.53%
More